Brazil’s CADE set to rule on Novamed-Medley deal, other cases
MLex Summary: Brazil’s competition authority is expected to vote on Nov. 18 on Novamed’s acquisition of Medley in the pharmaceutical sector. The Administrative Council for Economic Defense, or CADE, is also...To view the full article, register now.
Already a subscriber? Click here to view full article